» Articles » PMID: 8078424

Unique Properties of a Cytotoxic CD4+CD8+ Intraepithelial T-cell Line Established from the Mouse Intestinal Epithelium

Overview
Date 1994 Jan 1
PMID 8078424
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Growth factor-dependent gut intraepithelial lymphocyte (IEL) cell lines were established from a long-term in vitro culture of BALB/c IEL with syngeneic irradiated spleen cells in the presence of concanavalin A-stimulated spleen supernatant fluids. The cell lines were preferentially consisted of very limited thymoindependent subsets of IEL; i.e., Thy-1+CD5-TCR alpha beta+CD4+CD8 alpha+beta- (double-positive; DP) IEL and Thy-1+CD5-TCR alpha beta+CD4-CD8 alpha+beta- (CD8 single-positive; CD8 SP) IEL. The CD8 SP IEL cell line had cytotoxic activities and was triggered to proliferate by T-cell receptor (TCR)-directed stimuli. The DP IEL cell line expressed high levels of the CD3-TCR alpha beta, exhibited cytotoxic activity in redirected lysis assays, and had perforin in the cytoplasm, indicating the functional maturity of this cell line. However, the DP IEL cell line did not proliferate in response to TCR alpha beta-directed stimuli, which indicated that TCR alpha beta-mediated signalling was able to initiate cytotoxic function but not to induce proliferation of the DP IEL cell line. Although both cell lines were shown to have functional competence, they expressed J11d antigen which marks immaturity in thymocyte differentiation pathways. These results indicate that the established thymoindependent DP and CD8 SP IEL cell lines have unique properties distinct from DP thymocytes and CD8 SP peripheral T cells. Together with a recent report on freshly isolated DP IEL (10), the unique properties of the DP IEL cell line seems to support the notion that DP IEL may undergo a unique maturation process in the gut microenvironment.

Citing Articles

Cytolytic CD4 and CD8 Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease.

Bolivar-Wagers S, Larson J, Jin S, Blazar B Front Immunol. 2022; 13:864748.

PMID: 35493508 PMC: 9040077. DOI: 10.3389/fimmu.2022.864748.


Unconventional Intestinal Intraepithelial Lymphocytes in Health and Disease.

Nazmi A, McClanahan K, Olivares-Villagomez D Crit Rev Immunol. 2022; 41(4):23-38.

PMID: 35381141 PMC: 10165862. DOI: 10.1615/CritRevImmunol.2021039957.


CD4CD8αα IELs: They Have Something to Say.

Zhou C, Qiu Y, Yang H Front Immunol. 2019; 10:2269.

PMID: 31649659 PMC: 6794356. DOI: 10.3389/fimmu.2019.02269.


Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier.

Olivares-Villagomez D, Van Kaer L Trends Immunol. 2017; 39(4):264-275.

PMID: 29221933 PMC: 8056148. DOI: 10.1016/j.it.2017.11.003.


Innate CD8αα lymphocytes enhance anti-CD40 antibody-mediated colitis in mice.

Kumar A, Delgado A, Piazuelo M, Van Kaer L, Olivares-Villagomez D Immun Inflamm Dis. 2017; 5(2):109-123.

PMID: 28474503 PMC: 5418141. DOI: 10.1002/iid3.146.